-
公开(公告)号:US10459257B2
公开(公告)日:2019-10-29
申请号:US15048520
申请日:2016-02-19
Applicant: Monash University
Inventor: Chanaka Rupasinghe , Malin Premaratne , Ivan D. Rukhlenko
Abstract: A spaser device comprises a graphene resonator and a carbon nanotube (CNT) gain element coupled via exciton-plasmon interaction. The graphene resonator may be a rectangular or square graphene nanoflake (GNF), and the CNT gain element may be characterized by chirality vector (n,m) selected such that the CNT has semiconducting properties. The CNT gain element may be illuminated using a light source having a photon energy corresponding with a first exciton energy (E22) of the CNT, whereby excitons having a second exciton energy (E11) less than the first exciton energy are generated in the CNT, and coupled to a surface plasmon (SP) mode of the graphene resonator. When the rate of generation of excitons having the second exciton energy exceeds a gain threshold, continuous spasing is established within the spaser device.
-
公开(公告)号:US10294280B2
公开(公告)日:2019-05-21
申请号:US15327759
申请日:2015-07-21
Applicant: Monash University
Inventor: Fasseli Joseph Coulibaly
IPC: C07K14/005 , A61K39/12 , A61K39/00
Abstract: A fusion protein comprising an N-terminal portion and a C-terminal portion, wherein the N-terminal portion is a heterologous protein of interest which includes membrane proteins and antigens and the C-terminal portion is a polyhedrin targeting peptide which is derived from cypovirus polyhedrin and binds to cypovirus polyhedrin. The polyhedrin targeting peptide is described as a C-terminal portion of cypovirus polyhedrin and as C-terminal portion of cypovirus polyhedrin absent all or part of the N-terminal H1 helix sequence. Vectors and cells capable of expressing the fusion proteins are also provided. The fusion proteins fold with cypovirus polyhedrin to form modified complexes, polyhedra/microcubes useful in myriad applications, including as a platform technology for prophylactic or therapeutic vaccinations, therapeutics and diagnostics, including vaccines, therapeutics and diagnostics etc. employing membrane proteins.
-
公开(公告)号:US20190111148A1
公开(公告)日:2019-04-18
申请号:US15537095
申请日:2015-12-15
Applicant: Monash University
Inventor: Charles Reay Mackay , Di Yu , Remy Robert
Abstract: The invention relates to IL-21, to antibodies and related fragments thereof for binding to IL-21, to production of said antibodies and fragments and to use of said antibodies and fragments for detection and therapy of various conditions, in particular inflammation, infection and oncology.
-
公开(公告)号:US10245262B2
公开(公告)日:2019-04-02
申请号:US15300023
申请日:2015-04-01
Inventor: Alexandra Jane Corbett , James McCluskey , Lars Kjer-Nielsen , Zhenjun Chen , Jamie Rossjohn , Onisha Patel , Richard William Birkinshaw , Sidonia Barbara Guiomar Eckle , David Paul Fairlie , Ligong Liu , Jeffrey Yam Wing Mak
IPC: C07D239/54 , A61K31/513 , C07D239/545 , C07K14/74 , C07D239/60 , G01N33/569 , A61K47/55 , A61K47/64 , A61K38/00
Abstract: The present invention provides ligands which bind to MR1, some of which induce MR1 to bind to MAIT cells thereby activating or inhibiting MAIT cell activation.
-
公开(公告)号:US20190081347A1
公开(公告)日:2019-03-14
申请号:US15702997
申请日:2017-09-13
Inventor: Rana Mohtadi , Oscar Tutusaus , Douglas R. MacFarlane , Mega Kar
IPC: H01M10/056 , C07C217/08 , C07F5/02
Abstract: Electrolytes and electrochemical cells include a novel ionic liquid having a quaternary cation and a boron cluster anion. In some versions, the boron cluster anion will be a functionalized or unfunctionalized icosahedral boranyl or carboranyl anion. Electrochemical cells have an electrolyte including the ionic liquid. In some versions, the ionic liquid is used as a solvent to dissolve an ionic shuttle salt for transport of active material, with an optional co-solvent. Methods to synthesize the ionic liquid include contacting a boron cluster salt with a quaternary salt to form the ionic liquid by a metathesis reaction.
-
公开(公告)号:US20190016809A1
公开(公告)日:2019-01-17
申请号:US15907208
申请日:2018-02-27
Applicant: Monash University
Inventor: Charles Reay Mackay , Remy Michel Robert
Abstract: The invention relates to CXCR2, to antibodies and related fragments thereof for binding to CXCR2, to production of said antibodies and fragments and to use of said antibodies and fragments for detection and therapy of various conditions.
-
公开(公告)号:US20180362602A1
公开(公告)日:2018-12-20
申请号:US15771980
申请日:2016-10-28
Applicant: MONASH UNIVERSITY
Inventor: Matthew WATT , Ruth MEEX
CPC classification number: C07K14/4702 , A61K38/1709 , A61P3/10 , C07K16/46 , C07K2319/30
Abstract: The present invention relates to compositions, methods and kits for promoting glucose clearance in an individual. In particular, the compositions, methods and kits are particularly useful, but not limited to, the treatment of insulin resistance or type 2 diabetes. The invention provides a method of promoting blood glucose clearance in an individual, the method comprising administering SMOC1 to the individual. Preferably, the individual has an impaired ability to clear glucose from the blood. Typically, the individual displays a level of insulin resistance.
-
公开(公告)号:US20180344763A1
公开(公告)日:2018-12-06
申请号:US15555247
申请日:2016-03-02
Inventor: Katherine Elizabeth Sarah Locock , Laurence Meagher , Yue Qu , Ana Traven
CPC classification number: A61K31/785 , A01N47/44 , A61L15/24 , A61L15/44 , A61L27/34 , A61L27/54 , A61L29/085 , A61L29/16 , A61L2300/404 , C08L33/10 , A01N25/10
Abstract: The present invention relates to a method of adversely affecting a biofilm, the method comprising exposing the biofilm to a composition comprising an effective amount of polymer that incorporates within its backbone structure a first polymerised residue of ethylenically unsaturated monomer, said first polymerised monomer residue comprising a covalently bound moiety that (i) presents pendant from the backbone structure, and (ii) comprises a cationic functional group or precursor functional group thereof.
-
公开(公告)号:US10100311B2
公开(公告)日:2018-10-16
申请号:US15747697
申请日:2016-07-29
Applicant: Monash University
Inventor: Siew Yeen Chai , Robert Widdop , Tracey Gaspari , Huey Wen Lee
IPC: A61P1/16 , A61K31/395 , A61K31/351 , A61P13/12 , A61P9/00 , A61K31/4433 , C12N15/113
Abstract: The present invention relates to a method for the treatment of fibrosis, in particular cardiac fibrosis, comprising the administration of an inhibitor of insulin-regulated aminopeptidase (IRAP). Preferable the IRAP inhibitor is chosen from the group including HFI-419, HA-08, AL-40, HFI-437, Val-Tyr-Ile-His-Pro-Phe (otherwise known as angiotensin IV or ANG IV), c[Cys-Tyr-Cys]-His-Pro-Phe, and c[Hcy-Tyr-Hcy]-His-Pro-Phe.
-
公开(公告)号:US20180252947A1
公开(公告)日:2018-09-06
申请号:US15048520
申请日:2016-02-19
Applicant: Monash University
Inventor: Chanaka Rupasinghe , Malin Premaratne , Ivan D. Rukhlenko
CPC classification number: G02F1/0081 , A61K41/00 , A61K41/0023 , A61K41/0057 , A61N1/10 , A61N5/06 , A61N5/062 , B82Y20/00
Abstract: A spaser device comprises a graphene resonator and a carbon nanotube (CNT) gain element coupled via exciton-plasmon interaction. The graphene resonator may be a rectangular or square graphene nanoflake (GNF), and the CNT gain element may be characterised by chirality vector (n,m) selected such that the CNT has semiconducting properties. The CNT gain element may be illuminated using a light source having a photon energy corresponding with a first exciton energy (E22) of the CNT, whereby excitons having a second exciton energy (E11) less than the first exciton energy are generated in the CNT, and coupled to a surface plasmon (SP) mode of the graphene resonator. When the rate of generation of excitons having the second exciton energy exceeds a gain threshold, continuous spasing is established within the spaser device.
-
-
-
-
-
-
-
-
-